RVNC
Revance Therapeutics, Inc.
RVNC
RVNC
Delisted
RVNC was delisted on the 5th of February, 2025.
86 hedge funds and large institutions have $727M invested in Revance Therapeutics, Inc. in 2017 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 37 increasing their positions, 22 reducing their positions, and 4 closing their positions.
Holders
86
Holders Change
+8
Holders Change %
+10.26%
% of All Funds
2.15%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
12
Increased
37
Reduced
22
Closed
4
Calls
$776K
Puts
$909K
Net Calls
-$133K
Net Calls Change
-$471K
Top Buyers
| 1 |
1
Franklin Resources
San Mateo,
California
|
$89.1M |
| 2 |
2
Jennison Associates
New York
|
$9.99M |
| 3 |
3
Bank of New York Mellon
New York
|
$54.9M |
| 4 |
4
JPMorgan Chase & Co
New York
|
$95.7M |
| 5 |
PC
5
PointState Capital
New York
|
$11.6M |
